Celyad Oncology SA (EBR:CYAD)
Belgium · Delayed Price · Currency is EUR 0.1850
-0.0150 (-7.50%)
Dec 12, 2025, 5:29 PM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €8.28 million as of December 12, 2025. Its market cap has decreased by -73.77% in one year.
Market Cap
8.28M
Enterprise Value
8.32M
Revenue
186.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.19
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 8.28M, a decrease of -91.88%. That is a compound annual growth rate of -18.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 8.95M | -69.65% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | 92.30M | -31.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 46.10B |
| UCB SA | 45.73B |
| Financière de Tubize | 9.53B |
| Fagron NV | 1.51B |
| Ion Beam Applications | 332.47M |
| Nyxoah | 184.80M |
| Onward Medical | 180.98M |
| Hyloris Pharmaceuticals | 165.20M |